公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | 57 | 51 | |
2020 | 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | 59 | 47 | |
2011 | Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers | Nien H.-C.; JIN-CHUAN SHEU ; JIA-HORNG KAO ; Chou H.-C.; Su C.-W.; CHIEN-HUNG CHEN | Journal of Medical Virology | 5 | 4 | |
1996 | Absence of extensive genetic heterogeneity of hepatitis C virus in antibody-negative chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; PEI-MING YANG ; Lai M.Y.; Wang T.H.; DING-SHINN CHEN | Journal of Medical Virology | 11 | | |
1995 | Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers | HO-HSIUNG LIN ; JIA-HORNG KAO ; HONG-YUAN HSU ; YEN-HSUAN NI ; MEI-HWEI CHANG ; Huang S.-C.; Hwang L.-H.; PEI-JER CHEN ; Chen D.-S. | The Journal of Pediatrics | 181 | 113 | |
2018 | Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy | TUNG-HUNG SU ; Liao C.-H; CHEN-HUA LIU ; KAI-WEN HUANG ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Radiology | 17 | 14 | |
2001 | Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Hepatology | 73 | 68 | |
2008 | Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infection | TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 0 | 0 | |
2023 | Acute hepatitis C virus infection: clinical update and remaining challenges | CHEN-HUA LIU ; JIA-HORNG KAO | Clinical and molecular hepatology | 6 | 5 | |
1997 | Acute pancreatitis complicated by infarction of the spleen and spinal cord | SHU-CHEN WEI ; JIA-HORNG KAO ; Lee W.-Y.; Lin J.-T.; Wang T.-H. | Journal of the Formosan Medical Association | 5 | 2 | |
2015 | Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection | Hsu C.-S.; Liu W.-L.; Chao Y.-C.; Lin H.H.; TAI-CHUNG TSENG ; Wang C.-C.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 28 | 28 | |
2005 | Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-α therapy | JIN-YING LU ; LEE-MING CHUANG ; WEI-SHIUNG YANG ; TONG-YUAN TAI ; Lai, Ming-Yang; PEI-JER CHEN ; JIA-HORNG KAO ; Lee, Cha-Ze ; Lee, Hsuan-Shu | Liver international : official journal of the International Association for the Study of the Liver | 30 | 30 | |
2024 | Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories | Razavi-Shearer, D.; Child, H.; Razavi-Shearer, K.; Voeller, A.; Razavi, H.; Buti, M.; Tacke, F.; Terrault, N.; Zeuzem, S.; Abbas, Z.; Aghemo, A.; Akarca, U. S.; Al Masri, N.; Alalwan, A.; Blomé, M. Alanko; Jerkeman, A.; Aleman, S.; Kamal, H.; Alghamdi, A.; Alghamdi, M.; Alghamdi, S.; Al-Hamoudi, W.; Ali, E.; Aljumah, A.; Altraif, I.; Amarsanaa, J.; Asselah, T.; Baatarkhuu, O.; Babameto, A.; Ben-Ari, Z.; Berg, T.; Biondi, M.; Braga, W.; Brandão-Mello, C.; Brown, R.; Brunetto, M.; Cabezas, J.; Cardoso, M.; Martins, A.; Chan, H. L.Y.; Cheinquer, H.; Chen, C. J.; Yang, H. I.; PEI-JER CHEN ; Chien, C. H.; Chuang, W. L.; Garza, L. Cisneros; Coco, B.; Coffin, C.; Coppola, N.; Cornberg, M.; Craxi, A.; Crespo, J.; Cuko, L.; De Ledinghen, V.; Duberg, A. S.; Etzion, O.; Ferraz, M. L.; Ferreira, P.; Forns, X.; Foster, G.; Fung, J.; Gaeta, G.; García-Samaniego, J.; Genov, J.; Gheorghe, L.; Gholam, P.; Gish, R.; Glenn, J.; Hamid, S.; Hercun, J.; Hsu Y.-C.; Hu, C. C.; Huang, J. F.; Idilman, R.; Jafri, W.; Janjua, N.; Jelev, D.; Jia, J.; Kåberg, M.; Kaita, K.; JIA-HORNG KAO ; Khan, A.; Kim, D. Y.; Kondili, L.; Lagging, M.; Lampertico, P.; Lázaro, P.; Lazarus, J. V.; Lee, M. H.; Lim, Y. S.; Lobato, C.; Macedo, G.; Marinho, R.; Marotta, P.; Mendes-Correa, M. C.; Méndez-Sánchez, N.; Navas, M. C.; Ning, Q.; Örmeci, N. | Journal of hepatology | 5 | | |
2015 | Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy | Liang C.-C.; CHEN-HUA LIU ; Chung C.-S; Lin C.-K; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 7 | 6 | |
2012 | Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals | CHUN-JEN LIU ; Hsu C.-S.; JIA-HORNG KAO | Journal of Internal Medicine of Taiwan | 1 | | |
2022 | Advancing the global public health agenda for NAFLD: a consensus statement | Lazarus J.V.; Mark H.E.; Anstee Q.M.; Arab J.P.; Batterham R.L.; Castera L.; Cortez-Pinto H.; Crespo J.; Cusi K.; Dirac M.A.; Francque S.; Hickman I.J.; Hocking S.L.; Hunyady B.; Idilman R.; Isakov V.A.; Jamal M.H.; Jepsen P.; Iskandar N.J.; Song M.J.; Sudhamshu K.C.; George J.; Kakizaki S.; Kalamitsis G.; Kanwal F.; JIA-HORNG KAO ; Kaplan L.; Kawaguchi T.; Khader Y.; Kim S.U.; Kodjoh N.; Koek G.; Hagström H.; Koike K.; Komas N.P.; Korenjak M.; Kugelmas M.; Labidi A.; Lange N.F.; Lavine J.E.; Lazo M.; Lee N.; Lesmana C.R.A.; Huang T.T.-K.; CHUN-JEN LIU ; Long M.T.; Lopez-Jaramillo P.; Malekzadeh R.; Mahtab M.A.; Marchesini G.; Marinho R.; Vázquez S.E.M.; Mateva L.; Nlombi C.M.; Ismail M.H.; Melin P.; Mikolasevic I.; Milovanovic T.; Musso C.; Nakajima A.; Nava E.; Nersesov A.V.; Nikolova D.; Norris S.; Novak K.; Kautz A.; Oben J.; Ong J.P.; Onyekwere C.; Papatheodoridis G.; Paruk I.; Patel K.; Macedo M.P.; Penha-Gonçalves C.; Figueroa M.P.; Hofmann W.P.; Sarin S.K.; Petta S.; de Oliveira C.P.M.S.; Puri P.; Pan C.Q.; Rac M.; Ralston J.; Ramji A.; Razavi H.; Alvares-da-Silva M.R.; Roberts S.; Loomba R.; Roden M.; Rose T.; Rouabhia S.; Rovere-Querini P.; Rowe I.A.; Sadirova S.; Salupere R.; Saparbu T.; Sayegh R.; Sebastiani G.; Miller V.; Seki Y.; Selmo J.; Serme A.K.; Shaw J.E.; Shenoy T.; Sheron N.; Shibolet O.; Silva M.; Skrypnyk I.; Socha P.; Newsome P.N.; Soriano J.; Spearman C.W.; Sridharan K.; Suárez J.J.; Sheriff D.S.; Sung K.-C.; Swain M.; Tacke F.; Taheri S.; Tan S.-S.; Ninburg M.; Tapper E.B.; Yki-Järvinen H.; Thiele M.; Shawa I.T.; Tolmane I.; Torres E.A.; Trauner M.; Treeprasertsuk S.; Turcanu A.; Valantinas J.; Ocama P.; Vesterhus M.; Waked I.; Wild S.H.; Willemse J.; Wong R.J.; Xanthakos S.; Young D.Y.; Yu M.-L.; Zheng K.I.; Zeybel M.; Ratziu V.; Zheng M.-H.; the NAFLD Consensus Consortium; Rinella M.; Romero D.; Romero-Gómez M.; Schattenberg J.M.; Tsochatzis E.A.; Valenti L.; Wong V.W.-S.; Yilmaz Y.; Younossi Z.M.; Zelber-Sagi S.; Åberg F.; Adams L.; Khatry M.S.A.; Naamani K.A.; Murillo O.A.; Allen A.M.; Alnaser F.; Alqahtani S.A.; Alswat K.; Alvaro D.; Andrade R.J.; Arrese M.; Awuku Y.A.; Ayesha M.; Baatarkhuu O.; Bakieva S.; Basu R.; Bataller R.; Bedri S.; Bosi E.; Bourliere M.; Bruha R.; Bugianesi E.; Burra P.; Buti M.; Byrne C.D.; Calleja J.L.; Carrieri P.; Carter F.; Fernandez M.I.C.; Castillo-Lopez G.; Castro-Narro G.E.; Chan H.L.Y.; Chan W.-K.; Chang Y.; Colombo M.; Coppell K.J.; Corey K.; Craxi A.; Cryer D.; Dassanayake A.; Martins A.A.S.; de Ledinghen V.; DelPrato S.; Demaio A.; Desalegn H.; Dillon J.; Duseja A.; Dorairaj P.; Ekstedt M.; El Kassas M.; Elsanousi O.M.; Esmat G.; Fan J.-G.; Farpour-Lambert N.; Flisiak R.; Fouad Y.; Fuchs M.; Gani R.A.; Gerber L.; Ghazinyan H.; Gheorghe L.; Goh G.B.-B.; Grønbæk H.; Gulnara A.; Hamid S.; Hebditch V. | Nature Reviews Gastroenterology and Hepatology | 343 | 283 | |
2010 | Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link | Wang C.-C.; JIA-HORNG KAO | American Journal of Gastroenterology | 3 | 2 | |
2024 | An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan | Yu, Ming-Lung; Tai, Chi-Ming; Mo, Lein-Ray; Kuo, Hsing-Tao; Huang, Chung-Feng; Tseng, Kuo-Chih; Lo, Ching-Chu; Bair, Ming-Jong; Wang, Szu-Jen; Huang, Jee-Fu; Yeh, Ming-Lun; Chen, Chun-Ting; Tsai, Ming-Chang; Huang, Chien-Wei; Lee, Pei-Lun; Yang, Tzeng-Hue; Huang, Yi-Hsiang; Chong, Lee-Won; Chen, Chien-Lin; Yang, Chi-Chieh; Hung, Chao-Hung; Yang, Sheng-Shun; Cheng, Pin-Nan; Hsieh, Tsai-Yuan; Hu, Jui-Ting; Wu, Wen-Chih; Cheng, Chien-Yu; Chen, Guei-Ying; Zhou, Guo-Xiong; Tsai, Wei-Lun; Kao, Chien-Neng; Lin, Chih-Lang; Wang, Chia-Chi; Lin, Ta-Ya; Lin, Chih-Lin; Su, Wei-Wen; Lee, Tzong-Hsi; Chang, Te-Sheng; CHUN-JEN LIU ; Dai, Chia-Yen; Chen, Chi-Yi; JIA-HORNG KAO ; Lin, Han-Chieh; Chuang, Wan-Long; Peng, Cheng-Yuan | Hepatology international | | | |
2015 | Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial | Buti M.; Flisiak R.; JIA-HORNG KAO ; Chuang W.-L.; Streinu-Cercel A.; Tabak F.; Calistru P.; Goeser T.; Rasenack J.; Horban A.; Davis G.L.; Alberti A.; Mazzella G.; Pol S.; Orsenigo R.; Brass C. | Journal of Viral Hepatitis | 16 | 17 | |
2016 | All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study | JIA-HORNG KAO ; Lee Y.-J.; Heo J.; Ahn S.-H.; Lim Y.-S.; Peng C.-Y.; Chang T.-T.; Torbeyns A.; Hughes E.; Bhore R.; Noviello S. | Liver International | 22 | 25 | |